Latest news
Biophytis Wins Brazilian Approval for Phase 2 Obesity Trial of BIO101 - TipRanksTipRanks · Mon, 10 Aug 2026 23:38:42 GMTBiophytis (BPTSY) wins ANVISA approval for multi-regional BIO101 obesity trial - Stock TitanStock Titan · Mon, 10 Aug 2026 21:18:40 GMTBiophytis (BPTSY) 2025 loss €8.2m, low cash and going-concern uncertainty - Stock TitanStock Titan · Thu, 30 Jul 2026 15:33:02 GMT